Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA

Denis Lacombe

EORTC Headquarters

Trachea, bronchus and lung Prostate Pancreas Ovary Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Leukaemia Kidney, renal pelvis and ureter Corpus uteri Colorectum Cervix uteri Breast Brain, nervous system

Claudia Gravekamp

Treating pancreatic cancer with Listeria-32P

Pancreas

Stephen Schwartz

CORE INFRASTRUCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER)

Trachea, bronchus and lung Prostate Pancreas Kidney, renal pelvis and ureter Colorectum Breast

William G Cance

Focal Adhesion Kinase - Tumor Biology and Therapeutics

Pancreas Breast

Peter J Allen

Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas

Pancreas

Pathology

Joshua W Francis

A Novel Mechanism of GTPase Regulation: Arl2 Interaction with TBCD

Pancreas Breast

Alison P Klein

Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci

Pancreas

Pathology

Samuel I Gunderson

Preclinical Validation of U1 Adaptors for Suppression of KRAS in Pancreatic Cancer

Pancreas

Bulent Ozpolat

Targeting Kras in Pancreatic Cancer

Pancreas